Top Domestic Experts Regular Consultations Write New Chapter in Heavy Ion Development

——Professor Fan Ruitai, Standing Committee Member of the Chinese Medical Association Radiation Oncology Committee and Former Chairman of the Henan Provincial Medical Association Radiation Oncology Committee, Regularly Guides Work at the Lanzhou Heavy Ion Center

On September 23, Professor Fan Ruitai from the First Affiliated Hospital of Zhengzhou University in Henan Province arrived at the Lanzhou Heavy Ion Center of Gansu Wuwei Cancer Hospital, commencing a regular working model. This has injected new and powerful momentum into the development of our hospital in the field of cancer treatment.

Professor Fan Ruitai has achieved remarkable accomplishments in the field of radiation oncology, possessing extensive clinical experience and profound academic expertise. His regular participation in the treatment of heavy ion patients, tailoring scientific treatment plans for complex cases, has helped the hospital take new strides in the field of radiation oncology.

Gansu Wuwei Cancer Hospital is a state-owned public Class III Grade A specialized cancer hospital. The Lanzhou Heavy Ion Center is the second heavy ion clinical application center in China with independent intellectual property rights, operated by Gansu Wuwei Cancer Hospital. Together with the first Chinese heavy ion treatment system, the second Chinese heavy ion tumor treatment system was put into clinical operation at the Lanzhou Heavy Ion Center on November 15, 2024.

Professor Fan Ruitai's regular work aligns with the talent development strategy long upheld by our hospital. For many years, the hospital has long-term appointments with Professor Tatsuaki Kanai from the University of Gunma Faculty of Medicine in Japan, Professor Hirohiko Tsujii, former president of the National Institute of Radiological Sciences, Professor Jörg Hauffe, former president of the RPTC Munich Proton Therapy Centre in Germany, Professor Olga, Professor Yi-Min Jen, former chairman of the Taiwanese Society for Therapeutic Radiology and Oncology, Professor Chia-Ming Wu, a renowned radiation physicist from Chang Gung Memorial Hospital in Taiwan, and the team of Professor Wang Junjie, chairman of the Chinese Medical Association Radiation Oncology Committee. Recently, the hospital has further introduced Professor Yasuo Yoshioka from the Department of Radiation Oncology at the Japanese Foundation for Cancer Research, Professor György Kovács, Director of the Lübeck Brachytherapy Center and Education Program Director at Università Cattolica del Sacro Cuore in Italy, and Professor Tung-Ho Wu from the TMU Proton Therapy Center at Taipei Medical University Hospital for long-term work. The addition of these top experts has built an expert think tank covering the entire heavy ion treatment chain and integrating Eastern and Western wisdom, making the talent matrix even stronger.

We firmly believe that with the outstanding leadership of Professor Fan and other industry leaders, the Lanzhou Heavy Ion Center of Gansu Wuwei Cancer Hospital will undoubtedly use innovation as a powerful driving force, accelerating its journey to become an international top-tier heavy ion cancer diagnosis and treatment center integrating clinical practice, scientific research translation, and talent cultivation. This will reshape the landscape of cancer treatment, reignite the light of hope for cancer patients worldwide, and strongly drive China's cancer treatment cause to steadily advance toward international leadership, shining with brilliant light.

Lanzhou Heavy Ion Center

Gansu Wuwei Cancer Hospital is a state-owned public Class III Grade A specialized cancer hospital. The Lanzhou Heavy Ion Center is the second heavy ion clinical application center in China with independent intellectual property rights, operated by Gansu Wuwei Cancer Hospital. Together with the first Chinese heavy ion treatment system, the second Chinese heavy ion tumor treatment system was put into clinical operation at the Lanzhou Heavy Ion Center on November 15, 2024. As of now, the center has completed photon and heavy ion treatment for over 300 patients, covering diseases such as lung cancer, pancreatic cancer, liver cancer, and glioblastoma.

The Lanzhou Heavy Ion Center has established an elite talent system, building expert workstations led by 50 top authorities in the industry, including Professor Shen Wenjiang, Lifetime Honorary Professor of the Department of Radiation Oncology at Peking University Health Science Center, and Professor Xu Bo, Standing Committee Member of the Chinese Medical Association Radiation Oncology Committee. Professor Wang Junjie, Chairman of the Chinese Medical Association Radiation Oncology Committee, serves as the president, providing strong technical support for heavy ion treatment.

Simultaneously, the hospital is equipped with a series of cutting-edge medical devices such as the Varian VitalBeam medical linear accelerator, Elekta Infinity four-dimensional image-guided linear accelerator, 3.0T simulation positioning MRI, GE 256-slice high-end CT, and Varian Iridium-192 imported afterloader. These hardware facilities lay a solid foundation for heavy ion treatment, ensuring efficiency and precision in the process.

Aiming to create a comprehensive, full-lifecycle cancer treatment system, the hospital has established departments including Radiation Oncology, Medical Oncology/Hematology, Surgical Oncology, Integrated Traditional Chinese and Western Medicine Oncology Rehabilitation, Critical Care Medicine, Digestive Endoscopy Center, Imaging Department, Laboratory Department, Ultrasound Medicine Department, Blood Bank, and Hematology Center Laboratory. It offers comprehensive treatments including photon radiotherapy, chemotherapy, heavy ion therapy, internal medicine, surgical comprehensive therapy, as well as imaging, medical laboratory tests, ultrasound, and bone marrow cell morphology examinations.